Related Experiment Video

Updated: Jun 18, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Inhibition of C5-cytosine-DNA-methyltransferases

O V Kirsanova1, N A Cherepanova, E S Gromova

  • 1Faculty of Chemistry, Lomonosov Moscow State University, Moscow, Russia.

Biochemistry. Biokhimiia
|November 18, 2009
PubMed

Insights

DNA methylation errors drive cancer initiation and progression. This review explores C5-DNA-methyltransferase (MTase) inhibitors, including nucleoside and non-nucleoside types, for cancer therapy and MTase research.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Research

Background:

  • Genomic DNA methylation alterations, especially hypermethylation of tumor suppressor genes, are early indicators of tumor development.
  • Aberrant DNA methylation is a key factor in the initiation and progression of diverse cancers.

Purpose of the Study:

  • To review known nucleoside and non-nucleoside inhibitors of C5-DNA-methyltransferases (MTases).
  • To discuss the inhibitory mechanisms of these compounds.
  • To explore their applications in MTase research and cancer treatment.

Main Methods:

  • Literature review of nucleoside and non-nucleoside C5-DNA-methyltransferase inhibitors.
  • Analysis of reported inhibitory mechanisms.
  • Evaluation of current and potential applications in cancer therapy.

Main Results:

  • Categorization of inhibitors into nucleoside (reversible and irreversible) and non-nucleoside types.
  • Detailed discussion of diverse inhibitory mechanisms employed by these compounds.
  • Summary of their utility in studying MTase function and as potential anti-cancer agents.

Conclusions:

  • C5-DNA-methyltransferase inhibitors are crucial tools for understanding epigenetic dysregulation in cancer.
  • Both nucleoside and non-nucleoside inhibitors show promise for targeted cancer therapy.
  • Further research into MTase inhibitors can advance both fundamental epigenetics and clinical oncology.

More Related Videos

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C11:53

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C

Published on: June 1, 2018

Immunohistochemical Detection of 5-Methylcytosine and 5-Hydroxymethylcytosine in Developing and Postmitotic Mouse Retina07:50

Immunohistochemical Detection of 5-Methylcytosine and 5-Hydroxymethylcytosine in Developing and Postmitotic Mouse Retina

Published on: August 29, 2018

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.